RPg Family Wealth Advisory’s Pfizer PFE Stock Holding History

RPg Family Wealth Advisory’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-67,225	Closed	-$2.74M	–	119
2023 Q1	$2.74M	Buy	67,225 +1,056	+2%	+$45.6K	1.51%	25
2022 Q4	$3.39M	Sell	66,169 -64,460	-49%	-$3.09M	2.32%	14
2022 Q3	$5.96M	Buy	130,629 +371	+0.3%	+$18K	3.14%	8
2022 Q2	$6.83M	Sell	130,258 -314	-0.2%	-$16K	4.07%	3
2022 Q1	$6.76M	Sell	130,572 -14,698	-10%	-$763K	2.88%	7
2021 Q4	$8.58M	Buy	145,270 +509	+0.4%	+$25.2K	3.39%	5
2021 Q3	$6.23M	Buy	144,761 +2,408	+2%	+$107K	2.62%	9
2021 Q2	$5.57M	Buy	+142,353	New	+$5.54M	2.26%	11
2020 Q4	$5.11M	Buy	138,922 +138,458	+29,840%	+$5.08M	2.41%	12
2020 Q3	$16.1K	Hold	464	–	–	0.01%	232
2020 Q2	$14.4K	Hold	464	–	–	0.01%	246
2020 Q1	$14.4K	Hold	464	–	–	0.01%	220
2019 Q4	$17.2K	Sell	464 -644	-58%	-$22.9K	0.01%	226
2019 Q3	$37.8K	Hold	1,108	–	–	0.02%	179
2019 Q2	$45.5K	Hold	1,108	–	–	0.03%	167
2019 Q1	$44.6K	Sell	1,108 -1,370	-55%	-$54.9K	0.03%	176
2018 Q4	$103K	Sell	2,478 -571	-19%	-$23.7K	0.1%	72
2018 Q3	$127K	Hold	3,049	–	–	0.1%	72
2018 Q2	$105K	Sell	3,049 -214	-7%	-$7.31K	0.08%	78
2018 Q1	$110K	Hold	3,263	–	–	0.09%	62
2017 Q4	$112K	Hold	3,263	–	–	0.09%	57
2017 Q3	$111K	Sell	3,263 -2,953	-48%	-$94.9K	0.09%	64
2017 Q2	$198K	Buy	6,216 +2,959	+91%	+$93.3K	0.17%	49
2017 Q1	$106K	Buy	3,257 +1,091	+50%	+$34.4K	0.09%	71
2016 Q4	$66.7K	Sell	2,166 -211	-9%	-$6.44K	0.06%	101
2016 Q3	$76.4K	Sell	2,377 -1,195	-33%	-$40K	0.05%	94
2016 Q2	$119K	Buy	3,572 +917	+35%	+$29.3K	0.05%	79
2016 Q1	$74.7K	Buy	2,655 +2,084	+365%	+$59.5K	0.06%	103
2015 Q4	$17.5K	Buy	+571	New	+$18K	0.02%	157

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

RPg Family Wealth Advisory's PFE Position: Q2 2023 in Review

RPg Family Wealth Advisory sold out of Pfizer (PFE) in Q2 2023, closing a stake of 67,225 shares — an estimated $2.74M sold.

RPg Family Wealth Advisory first reported a position in PFE in Q4 2015 and held it in 29 quarters. The position peaked at $8.58M in Q4 2021. 3,044 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

RPg Family Wealth Advisory reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
RPg Family Wealth Advisory sold 67,225 Pfizer shares in Q2 2023, an estimated $2.74M.
RPg Family Wealth Advisory first reported a position in Pfizer in Q4 2015 and held it in 29 quarters.
RPg Family Wealth Advisory's Pfizer position peaked at $8.58M in Q4 2021.
3,044 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on RPg Family Wealth Advisory's 13F filing for Q2 2023, filed 9 Aug 2023.